Centre clears Mumbai's Haffkine institute to make Covaxin

Gallery

MORE...

Sports

Paralympics: BAI announces Rs 50 lakh cash reward for medallist para-shuttlers

Badminton Federation of India (BAI) on Tuesday announced the cash reward of Rs 50 lakh for

Laver Cup: Tiafoe upsets Medvedev, Alcaraz pulls Team Europe level with Team World

Cincinnati Open: Tiafoe, Hurkacz, Rune and Draper in the quarters

Paris Olympics: Abhinav Bindra 'completely gutted' after Vinesh Phogat's disqualification

Paris Olympics: USA, China in Top-2, India slip to 60th

Paris Olympics, Medal Tally: USA jump to top, China slip to 2nd; India on 57th

MORE...

Centre clears Mumbai's Haffkine institute to make Covaxin

Last Updated : 16 Apr 2021 10:40:48 AM IST

Covaxin

In a major step to ramp up vaccine production amid the Covid-19 second wave, the Centre has approved production of Corona vaccines from the Maharashtra government-owned Haffkine Institute in Mumbai.

Since the past month, Chief Minister Uddhav Thackeray had repeatedly requested Prime Minister Narendra Modi to allow production of vaccines in the renowned institution in central Mumbai.

The central approval came late on Thursday night green-flagging the 122-year-old Haffkine Institute, Parel, to produce the Bharat Biotech's Covaxin for one-year under a technology transfer agreement.

Shortly after the announcement, Thackeray thanked the PM for the formal nod, sent by the Department of Science & Technology Secretary to state Chief Secretary Sitaram Kunte of the approval for a period of 12 months.

The Haffkine Institute has the capacity to produce 22-crore doses annually, which would immensely help the ongoing Vaccination drive in the country with complaints of vaccine shortages coming up from several states including Maharashtra.